IMUC (IMUC) Stock Price & Analysis
IMUC (IMUC) rose 0.00% to USD 0.15 as of September 8, 2026 at 10:16 UTC, according to Nexqual real-time market data.
IMUC last closed at USD 0.15; the session ranged USD 0.15–0.15 on volume of 200 shares. Market capitalization is —, with a 52-week range of USD 0.04–0.34 (PNK). Source: Nexqual, September 8, 2026 at 10:16 UTC.
Key Statistics (as of September 8, 2026 at 10:16 UTC)
| Price | USD 0.15 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.15 |
| Open | USD 0.15 |
| Day Range | USD 0.15 – 0.15 |
| 52-Week Range | USD 0.04 – 0.34 |
| Volume | 200 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (IMUC)
Nexqual's technical model rates IMUC "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:16 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 47.26 (neutral) |
| vs SMA50 | Below (USD 0.2) |
| MACD | -0.01 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NWBO | Northwest Biotherapeutics, Inc. | USD 0.17 | ▲ 0% |
| BGMSP | Bio Green Med Solution Inc. | USD 2.81 | ▲ 0% |
| ANTH | ANTHERA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| CLDX | Celldex Therapeutics, Inc. | USD 39.68 | ▲ 0.51% |
| NAVBQ | Navidea Biopharmaceuticals, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:16 UTC. This page is informational and not investment advice.